Lowering Insulin Costs: Sanofi Seeks HHS Support For Expanding Assistance To Medicare Patients

HHS endorsement of company-sponsored discount programs for cash-paying customers with Medicare would be preferable to lowering list pricing.

Diabetes

More from Pricing Debate

More from Market Access